Skip to main content

Table 2 Univariable logistic regression analysis

From: Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study

Predictors of PAH

OR (95 % CI)

p

GAVE

1.42 (0.8–2.5)

0.21

Reflux oesphagitis

1.07 (0.8–1.5)

0.71

Oesphageal stricture

2.59 (1.7–4.0)

<0.001

Oesphageal dysmotility

1.43 (0.8–2.5)

0.20

Bowel dysmotility

1.47 (1.0–2.2)

0.05

Anal incontinence

1.66 (1.1–2.5)

0.01

Myocardial

1.14 (0.6–2.2)

0.70

Pericardial effusion

4.44 (2.7–7.4)

<0.001

Renal crisis

0.59 (0.2–2.5)

0.47

Synovitis

0.96 (0.6–1.5)

0.86

Joint contractures

1.79 (1.2–2.6)

0.002

Calcinosis

2.65 (1.8–3.9)

<0.001

Digital Ulcers

1.85 (1.3–2.7)

0.001

Sicca symptoms

2.23 (1.5–3.4)

<0.001

ILD

1.95 (1.4–2.8)

<0.001

Telangiectasia

3.02 (1.5–6.0)

0.002

Disease duration at recruitment

1.03 (1.01–1.05)

<0.001

Limited systemic sclerosis

1.13 (0.8–1.7)

0.54

Autoantibodies

 Anti-centromere pattern

1.36 (0.9–1.9)

0.11

 Scl 70 + ve

0.49 (0.2–0.9)

0.05

 RNA polymerase III + ve

0.89 (0.4–1.9)

0.78

  1. Abbreviations: GAVE gastric antral vascular ectasia, ILD interstitial lung disease, PAH pulmonary arterial hypertension